Short description
Biotie is a specialized drug development company focused on the central nervous system and inflammatory diseases.
Description
Biotie is a specialized drug development company focused on central nervous system and inflammatory diseases. It has several innovative small molecule and biological drug candidates at different stages of clinical development. Biotie's products address diseases with high unmet medical need and significant market potential, including addiction and a broad range of inflammatory conditions such as rheumatoid arthritis and chronic obstructive pulmonary disease (COPD). The most advanced product, nalmefene for alcohol dependence, is currently in phase III clinical development by licensing partner H. Lundbeck A/S.
Last funding
Nopepepe
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Finans, Nigde, Turkey, Europe
Founded on
January 1, 1992
Exited on
June 19, 2015
Went public on
June 19, 2015
Delisted on
June 13, 2016
Stock symbol
BITI
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$34056 - 789030
Sign in for full access
Investors
Cannot Access
Sign in for full access
Founders
Markku Jalkanen